Data Bridge Market Research analyses that the multiple sclerosis treatment market was valued at USD 25.38 billion in 2021 and is expected to reach USD 34.73 billion by 2029, registering a CAGR of 4.00% during the forecast period of 2022 to 2029.

Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells.

Government as well as non-government groups are promoting the understanding of the condition and thus are likely to encourage growth of the global multiple sclerosis drugs market. The government and non-governmental groups support a range of efforts and p...

Multiple sclerosis is a neurological condition that affects the central nervous system and optic nerves